Codes / ICD10CM / T49.0X4A

T49.0X4A Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined, initial encounter (ICD Code: T49.0X4A)

Summary

This condition involves poisoning from topical medications classified as local antifungal, anti-infective, or anti-inflammatory agents, where the intent or circumstances of exposure are unclear. It is documented during the initial encounter with the patient.

Causes

Poisoning may result from accidental ingestion, improper application, or misuse of topical formulations. The undetermined nature suggests insufficient information to classify the exposure as accidental, intentional, or other at the time of initial assessment.

Risk Factors

  • Lack of clear documentation about the circumstances of exposure.
  • Inability to obtain a reliable history from the patient (e.g., due to altered mental status or communication barriers).
  • Use of medications in settings where intent is ambiguous (e.g., self-administration without supervision).

Symptoms

Symptoms vary by agent and exposure route. Local effects may include skin irritation, rash, or burning. Systemic effects (e.g., nausea, dizziness) can occur with significant absorption. The severity depends on the drug and amount involved.

Diagnosis

Diagnosis relies on clinical evaluation, including history of exposure, physical examination, and laboratory tests to assess drug levels or organ function. The "undetermined" classification is used when intent or circumstances cannot be confirmed initially.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and preventing further absorption. This may include decontamination, supportive care, and monitoring for systemic effects. Specific antidotes are not typically available for these agents.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure and timely intervention. Follow-up care may involve monitoring for delayed reactions or complications. Re-evaluation may be needed if new information about the exposure emerges.

Complications

Potential complications include skin damage, systemic toxicity, or organ injury from absorbed drugs. Severe cases may require intensive care for respiratory, neurological, or cardiovascular support.

Lifestyle & Prevention

Prevention involves proper storage of medications, clear dosing instructions, and supervision during application. Educating patients on safe use and recognizing signs of adverse reactions can reduce risks.

When to Seek Professional Help

Seek immediate medical attention if exposure is suspected, especially with symptoms like severe skin reactions, nausea, dizziness, or altered consciousness. Prompt care is critical for managing toxicity.

Tips for Medical Coders

Document the "undetermined" intent clearly in the medical record, as this supports the T49.0X4A code. Include details about the initial encounter and any available exposure history to justify the classification.

Book a walkthrough

T49.0X4A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.